Powered by: Motilal Oswal
22/08/2022 12:31:24 PM | Source: Axis Securities Ltd
Weekly Tech Picks - Astra Microwave Products Ltd, Emami Ltd, Thermax Ltd, Sun Pharma Advanced Research Company Ltd By Axis Securities
News By Tags | #5481 #3050 #163 #1466 #2333
Weekly Tech Picks - Astra Microwave Products Ltd, Emami Ltd, Thermax Ltd, Sun Pharma Advanced Research Company Ltd By Axis Securities

Astra Microwave Products Limited

• On the weekly time frame the stock has decisively broken out one year “consolidation zone” breakout at 292 levels on a closing basis . This breakout is accompanied with huge volumes indicating increased participation

• The stock is well placed above 20, 50, 100 and 200 day SMA’s which reconfirms bullish trend Astra Microwave Products Limited Weekly Tech Picks 19 August,2022reconfirms bullish trend

• On the daily and the weekly time frame, the stock has entered in up trend forming a series of higher tops and bottoms

• The daily and weekly strength indicator RSI is in bullish mode along with positive crossover which supports rising strength in near term.

• The above analysis indicate an upside of 338-351 levels.

• *Holding period is 3 to 4 weeks.

Buy Astra Microwave Products Limited CMP: 308 Buy Range: 302-296 Stop loss: 280 Upside: 13% - 17%

Emami Limited

• On the daily time frame, the stock has observed four months “cup & handle” formation breakout at 480 levels along with rising volumes

• The stock is well placed above its 20,50 ,100 and 200-day SMA’s which reconfirm bullish sentiments

• The daily “band Bollinger” buy signal 19 August,2022indicate increased momentum

• On the daily and weekly time frame, the stock has entered in up trend forming a series of higher tops and bottoms

• The daily and weekly strength indicator RSI is in positive terrain and sustaining above 50 mark indicating sustained strength

• The above analysis indicate upside of 530-555 levels. *Holding period is 3 to 4 weeks.

Buy Emami Limited CMP: 490 Buy Range: 485-477 Stop loss: 458 Upside: 10% - 15%

Sun Pharma Advanced Research Company Limited

• On the daily chart, the stock has confirmed four months “inverse head & shoulder ” breakout around 233 levels on a closing basis

• Rising volumes at breakout zone indicates increased participation

• The stock is well placed above its 20, 50 and 100 day SMA’s and sustaining 19 August,202250 and 100 day SMA’s and sustaining above the same which reconfirm bullish sentiments

• The daily “band Bollinger” buy signals indicate increased momentum

• The daily and weekly strength indicator RSI continue to remain bullish and quoting above 50 mark which signals sustained and rising strength

• The above analysis indicate upside of 265-275 levels.

Buy Sun Pharma Advanced Research Company Limited CMP: 242 Buy Range: 238-234 Stop loss: 218 Upside: 12% - 17%

Thermax Limited

• On the daily chart, the stock has confirmed “triangle“ breakout at 2200 levels

• This breakout is accompanied with huge volume spurt indicating increased participation at breakout zone

• On the daily and weekly time frames, the stock has witnessed trend reversal indicating bullish sentiments 19 August,2022

• The stock is well placed above its 20, 50,100 and 200 - day SMA support zone which reconfirm bullish sentiments

• The daily and weekly “band Bollinger” signals increased momentum

• The daily and weekly strength indicator RSI is in bullish mode which supports rising strength

• The above analysis indicate upside of 2455-2565 levels. *Holding period is 3 to 4 weeks

Buy Thermax Limited CMP: 2256 Buy Range: 2250-2206 Stop loss: 2750 Upside: 10% - 15%

 

To Read Complete Report & Disclaimer Click Here

 

For More Axis Securities Disclaimer  https://simplehai.axisdirect.in/disclaimer-home
SEBI Registration number is INZ000161633

 

Above views are of the author and not of the website kindly read disclaimer

 

 

 

 

 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here